AOK Nordost. Die Gesundheitskasse.
- Country
- Germany
- Type
- Beneficiary
- Calls awarded
- 38
- Grants received
- 2
Funding record
- 2 grants on record
- €129,875 awarded in total
- 2018–2018 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
Calls from this organisation
- Abschluss nicht-exklusiver Liefervereinbarung mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open-House-Verfahrens" der AOK Nordost
- Brivaracetam
- Teduglutid
- Testosteron (nur Dosiergel)
- Apixaban
- Atomoxetin
- Doravirin
- Entecavir
- Interferon beta 1-a (Rebif)
- Ipratropium bromid
- Leuprorelin
- Miglustat
- Nevirapin
- Octreotid
- Pazopanib
Grants received
- Personalised Medicine by Predictive Modeling in Stroke for better Quality of Life
- Big Data for Medical Analytics
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Source: Datenservice Öffentlicher Einkauf (Bundesministerium für Wirtschaft und Klimaschutz). CC0 1.0 (CC-ZERO) — no conditions.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.